Listed by the USPTO as BELL, SARA ELIZABETH
Tech Center 1600 • Art Units: 1621 1625
This examiner grants 69% of resolved cases
BELL, Sara Elizabeth has resolved 64 cases in Tech Center 1600 and records a 68.8% allowance rate. The 38.2% interview lift indicates that interviews may be especially useful for improving prosecution outcomes. The median time to allowance is 1356 days, so counsel should prepare for a prolonged timeline while using interviews to clarify the key patentability issues.
Novartis AG, Bristol-Myers Squibb Company, and Mindset Pharma Inc. are the leading companies. Barnes & Thornburg LLP (IN), MORRISON & FOERSTER LLP, and Acuity Law Group, P.C. are the leading firms. Applications in art unit 1621 may benefit from detailed technical preparation and prompt written follow-up.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18286185 | TREATMENT METHODS AND COMPOSITIONS COMPRISING PERAMPANEL | Final Rejection | The Johns Hopkins University |
| 18294129 | METHOD OF TREATING POSTTRAUMATIC STRESS DISORDER | Non-Final OA | Jazz Pharmaceuticals Ireland Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy68.8% of resolved applications examined by Sara Elizabeth Bell were allowed (64 resolved cases), compared with 46.0% across Art Unit 1621 over the last five years.
This examiner's interview lift is +38.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sara Elizabeth Bell took 1,356 days on average from filing to allowance.
Sara Elizabeth Bell examines applications in Art Unit 1621 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
